The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.
Journal article
Goldswain H. et al, (2023), Genome Biol, 24
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region
Journal article
Emmenegger M. et al, (2023), iScience, 26, 105928 - 105928
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Journal article
Liew F. et al, (2023), eBioMedicine, 87, 104402 - 104402
Publisher Correction: A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.
Journal article
Bahar MW. et al, (2022), Commun Biol, 5
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75.
Journal article
Huo J. et al, (2022), Cell reports
A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation.
Journal article
Bahar MW. et al, (2022), Commun Biol, 5
Switching of Receptor Binding Poses between Closely Related Enteroviruses
Journal article
Zhou D. et al, (2022), Viruses, 14, 2625 - 2625
Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6.
Journal article
Dijokaite-Guraliuc A. et al, (2022), Cell discovery, 8
Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum.
Journal article
Huo J. et al, (2022), Cell discovery, 8
Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study
Journal article
Vink E. et al, (2022), Open Forum Infectious Diseases, 9
Production and Characterisation of Stabilised PV-3 Virus-like Particles Using Pichia pastoris.
Journal article
Sherry L. et al, (2022), Viruses, 14
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.
Journal article
Siggins MK. et al, (2022), Immunology
Nonlytic cellular release of hepatitis A virus requires dual capsid recruitment of the ESCRT-associated Bro1 domain proteins HD-PTP and ALIX.
Journal article
Shirasaki T. et al, (2022), PLoS pathogens, 18
Delineating organizational principles of the endogenous L-A virus by cryo-EM and computational analysis of native cell extracts
Preprint
Schmidt L. et al, (2022)
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
Journal article
Tuekprakhon A. et al, (2022), Cell, 185, 2422 - 2433.e13
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection.
Journal article
Wei J. et al, (2022), Nat Commun, 13
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
Journal article
Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18
Further antibody escape by Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Preprint
Tuekprakhon A. et al, (2022)
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Journal article
Wei J. et al, (2022), Nature Medicine, 28, 1072 - 1082
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status
Journal article
Lumley SF. et al, (2022), Clinical Infectious Diseases, 74, 1208 - 1219
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Journal article
Wei J. et al, (2022), Nature Medicine
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Journal article
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Purification of African Swine Fever Virus.
Journal article
Shimmon GL. et al, (2022), Methods in molecular biology (Clifton, N.J.), 2503, 179 - 186
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2.
Journal article
Huang K-YA. et al, (2022), Theranostics, 12, 1 - 17
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
Journal article
Dejnirattisai W. et al, (2021), Lancet (London, England)
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Preprint
Dejnirattisai W. et al, (2021)
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective.
Journal article
Halawa S. et al, (2021), Nature reviews. Cardiology
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Journal article
Tan TK. et al, (2021), Nature Communications, 12
Bacteriophage PRD1 as a nanoscaffold for drug loading.
Journal article
Duyvesteyn HME. et al, (2021), Nanoscale
Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines
Journal article
Bahar MW. et al, (2021), npj Vaccines, 6
Sex in Chemsex: Sexual Response, Motivations, and Sober Sex in a Group of Italian Men Who Have Sex With Men With Sexualized Drug Use.
Journal article
Nimbi FM. et al, (2021), The journal of sexual medicine, 18, 1955 - 1969
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants.
Journal article
Liu C. et al, (2021), Cell host & microbe
iNEXT-Discovery and Instruct-ERIC: Integrating High-End Services for Translational Research in Structural Biology.
Journal article
Wienk H. et al, (2021), Journal of visualized experiments : JoVE
Chems4EU: chemsex use and its impacts across four European countries in HIV-positive men who have sex with men attending HIV services.
Journal article
Whitlock GG. et al, (2021), HIV medicine, 22, 944 - 957
Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status
Journal article
Eyre DW. et al, (2021), Clinical Microbiology and Infection, 27, 1516.e7 - 1516.e14
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
Journal article
Wei J. et al, (2021), Nature Microbiology, 6, 1140 - 1149
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers
Journal article
Lumley SF. et al, (2021), Clinical Infectious Diseases, 73, e699 - e709
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Journal article
Liu C. et al, (2021), Cell, 184, 4220 - 4236.e13
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Journal article
Wei J. et al, (2021)
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Preprint
Wei J. et al, (2021)
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Preprint
Wei J. et al, (2021)
Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.
Journal article
Allen JD. et al, (2021), Biochemistry, 60, 2153 - 2169
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.
Journal article
Redhead MA. et al, (2021), Scientific reports, 11
Antibody evasion by the P.1 strain of SARS-CoV-2
Journal article
Dejnirattisai W. et al, (2021), Cell, 184, 2939 - 2954.e9
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Journal article
Zhou D. et al, (2021), Cell, 184, 2348 - 2361.e6
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Journal article
Supasa P. et al, (2021), Cell, 184, 2201 - 2211.e7
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Journal article
Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22
Site-specific steric control of SARS-CoV-2 spike glycosylation.
Journal article
Allen JD. et al, (2021), bioRxiv
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Journal article
Huo J. et al, (2021), Nature Structural & Molecular Biology, 28, 326 - 326
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
Journal article
Pouwels KB. et al, (2021), The Lancet Public Health, 6, e30 - e38